The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Rutkovskaia N.V.

Nauchno-issledovatel'skiĭ institut kompleksnykh problem serdechno-sosudistykh zabolevaniĭ SO RAMN, Kemerovo

Stasev A.N.

FGBU NII KPSSZ SO RAMN, Kemerovo

Odarenko Iu.N.

Nauchno-issledovatel'skiĭ institut kompleksnykh problem serdechno-sosudistykh zabolevaniĭ SO RAMN, Kemerovo

Biological prostheses of heart valves: realities, problems and solutions

Authors:

Rutkovskaia N.V., Stasev A.N., Odarenko Iu.N.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(6): 70‑77

Read: 1283 times

Download PDF (RU)
Contact the author
Table of contents

BIOLOGICAL PROSTHESES OF HEART VALVES: REALITIES, PROBLEMS AND SOLUTIONS
BIOLOGICAL PROSTHESES OF HEART VALVES: REALITIES, PROBLEMS AND SOLUTIONS

To cite this article:

Rutkovskaia NV, Stasev AN, Odarenko IuN. Biological prostheses of heart valves: realities, problems and solutions. Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(6):70‑77. (In Russ.)

ЭндоКард
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Treatment of postoperative complications in cardiothoracic surgery: single-center 10-year expe­rience. Piro­gov Russian Journal of Surgery. 2024;(12-2):66-71
Cere­bral protection in transcatheter aortic valve implantation. Piro­gov Russian Journal of Surgery. 2024;(12-2):150-158
Capsular contracture after reco­nstructive plastic surgery for breast cancer. P.A. Herzen Journal of Onco­logy. 2024;(6):78-83
Short- and mid-term outcomes after posterolateral endo­scopic discectomy in patients with lumbosacral junction disc herniations. Piro­gov Russian Journal of Surgery. 2024;(12):52-59
Complications after Laser Treatment. Journal of Venous Diso­rders. 2024;(4):317-327
Current trends in orga­nizing the care for patients with acquired heart valve disease. Russian Cardiology Bulletin. 2024;(4):5-12
Instrumental and labo­ratory indi­cators in evaluating the effe­ctiveness of suba­ntral sinus lifting in severe bone atro­phy. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(1):48-55
Early complications after surgical treatment of spontaneous pneumothorax: risk factors analysis. Piro­gov Russian Journal of Surgery. 2025;(3):24-32
The role of early predictors in diagnosis of stapler suture and anastomotic failure in bariatric patients. Piro­gov Russian Journal of Surgery. 2025;(3):76-86
Possibilities surgical treatment of atypical forms of pelvic organ prolapse. Endo­scopic Surgery. 2025;(2):35-42
Abstract:

Keywords:

acquired heart diseases
prosthetics heart valves
biological prostheses
mechanical prostheses
indications
prosthesis dysfunction
the frequency of the reoperation
complications

Authors:

Rutkovskaia N.V.

Nauchno-issledovatel'skiĭ institut kompleksnykh problem serdechno-sosudistykh zabolevaniĭ SO RAMN, Kemerovo

Stasev A.N.

FGBU NII KPSSZ SO RAMN, Kemerovo

Odarenko Iu.N.

Nauchno-issledovatel'skiĭ institut kompleksnykh problem serdechno-sosudistykh zabolevaniĭ SO RAMN, Kemerovo

Close metadata

References:

  1. Astapov D.A. Biologicheskie protezy pri khirurgicheskom lechenii klapannykh porokov serdtsa u vzroslykh bol'nykh: Avtoref. dis. … d-ra med. nauk. Novosibirsk 2012.
  2. Barbarash L.S., Karas'kov A.M., Semenovskii M.L. i dr. Bioprotezy klapanov serdtsa v Rossii: opyt trekh klinik. Patol krovoobr i kardiokhir 2011; 2: 21-26.
  3. Barbarash L.S., Karas'kov A.M., Semenov I.I. i dr. Infektsionnyi endokardit v strukture disfunktsii bioprotezov "Kemkor" i "Perikor". Patol krovoobr i kardiokhir 2010; 1: 26-30.
  4. Barbarash L.S., Rogulina N.V., Odarenko Yu.N., Zhuravleva I.Yu. K voprosu o taktike vybora proteza dlya mitral'noi pozitsii: sravnitel'naya otsenka 16-letnikh rezul'tatov primeneniya mekhanicheskogo proteza "MIKS" i biologicheskogo proteza "KemKor". Grudnaya i serdechno-sosud khir 2012; 2: 12-19.
  5. Barbarash L.S., Grigor'ev E.V., Plotnikov G.P. i dr. Struktura poliorgannoi nedostatochnosti posle kardiokhirurgicheskikh vmeshatel'stv. Obshchaya reanimatol 2010; 5: 38-41.
  6. Barbarash L.S., Zhuravleva I.Yu. Evolyutsiya bioprotezov klapanov serdtsa: dostizheniya i problemy dvukh desyatiletii. Kompleksnye probl serdechno-sosudistykh zabol 2012; 1: 4-11.
  7. Bokeriya L.A., Gudkova R.G. Serdechno-sosudistaya khirurgiya 2011. Bolezni i vrozhdennye anomalii sistemy krovoobrashcheniya. M 2012.
  8. Zhuravleva I.Yu., Gorbunova E.V., Rutkovskaya N.V. i dr. Kachestvo antikoagulyantnoi terapii varfarinom u bol'nykh s protezami klapanov serdtsa. Grudnaya i serdechno-sosud khir 2012; 3: 60-64.
  9. Karas'kov A.M., Nazarov V.M., Zheleznev S.I. i dr. Disfunktsii iskusstvennykh klapanov serdtsa. Novosibirsk: Akademicheskoe izdatel'stvo Geo 2008.
  10. Rogulina N.V., Odarenko Yu.N., Barbarash L.S. Mekhanicheskie i biologicheskie protezy serdtsa pri mitral'nykh porokakh: rezul'taty primeneniya. Serdechno-sosud zabol 2010; 6: 81.
  11. Shikhverdiev N.N., Khubulava G.G., Marchenko S.P. Diagnostika i lechenie oslozhnenii u bol'nykh s iskusstvennymi klapanami serdtsa. M: Foliant 2006.
  12. Antonini-Canterin F., Zuppiroli A., Popescu B.A. et al. Effect of statins on the progression of bioprosthetic aortic valve degeneration. Am J Cardiol 2003; 92: 12: 1479-1482.
  13. Ayegnon K., Aupart M., Bourguignon T. et al. A 25-year experience with Carpentier-Edwards Perimount in the mitral position. Asian Cardiovasc Thorac Ann 2011; 19: 1: 14-19.
  14. Ben Ismail M., Abid F., Trabelsi S., Taktak M., Fekih M. Cardiac valve prostheses, anticoagulation, and pregnancy. Br Heart J 1986; 55: 1: 101-105.
  15. Bettadapur M., Griffin B., Asher C. Caring for patients with prosthetic heart valves. Cleve Clin J Med 2002; 69: 75-87.
  16. Bloomfield P. Choice of heart valve prosthesis. Heart 2002; 87: 6: 583-589.
  17. Bonow R., Carabello B., Chatterjee K. et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006; 48: 3: e1-e148.
  18. Borger M., Ivanov J., Armstrong S. et al. Twenty-year results of the Hancock II bioprosthesis. J. Heart Valve Dis 2006; 15: 1: 49-55.
  19. Briand M., Pibarot P., Després J.-P. et al. Metabolic Syndrome Is Associated With Faster Degeneration of Bioprosthetic Valves. Circulation 2006; 114: 1: Suppl: I-512-I-517.
  20. Brown J., O'Brien S., Wu C. et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009; 137: 1: 82-90.
  21. Cannegieter S., Rosendaal F., Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635-641.
  22. Edwards M., Ratnatunga C., Dore C. et al. Thirty day mortality and long-term survival following surgery for prosthetic endocarditis: a study from UK heart valve registry. Eur J Cardiothorac Surg 1998; 14: 156-164.
  23. Farivar R.S., Cohn L.H. Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation. J Thorac Cardiovasc Surg 2003; 126: 4: 969-975.
  24. Fedoruk L.M., Jamiesjn E., Lung H. et al. Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis. J Thorac Cardiovasc Surg 2009; 137: 236-333.
  25. Gilmanov D., Bevilacqua S., Mazzone A., Glauber M. Do statins slow the process of calcification of aortic tissue valves? Int Cardiovasc Thorac Surg 2010; 11: 3: 297-301.
  26. Hall J.G. Embryopathy associated with oral anticoagulant therapy. Birth Defects Orig Artic Ser 1976; 12: 5: 33-37.
  27. Hammermeister K., Sethi G., Henderson W. et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000; 36: 4: 1152-1158.
  28. Hung L., Rahimtoola S. Prosthetic heart valves and pregnancy. Circulation 2003; 107: 9: 1240-1246.
  29. Keogh B., Walton P.K.H., Kinsman R. Third European Adult Cardiac Surgical Database Report. Dendrite Clinical Systems Limited 2007.
  30. Kirali K., Guler M., Tuncer A. et al. Fifteen-year clinical experience with the Biocor porcine bioprostheses in the mitral position. Ann Thorac Surg 2001; 71: 3: 811-815.
  31. Kulik A., Masters R., Bédard P. et al. Postoperative lipid-lowering therapy and bioprosthesis structural valve deterioration: justification for a randomised trial? Eur J Cardiothorac Surg 2010; 37: 1: 139-144.
  32. Kulik A., Rubens F., Wells P. et al. Early Postoperative Anticoagulation After Mechanical Valve Replacement: A Systematic Review. Ann Thorac Surg 2006; 81: 2: 770.
  33. Maciejewski M., Piestrzeniewicz K., Bielecka-Dabrowa A., Walczak A. Biological artificial valve dysfunction - single-centre, observational echocardiographic study in patients operated on before age 65 years. Arch Med Sci 2011; 7: 6: 993-999.
  34. Manji R.A., Zhu L.F., Nijjar N.K. et al. Glutaraldehyde-Fixed Bioprosthetic Heart Valve Conduits Calcify and Fail From Xenograft Rejection. Circulation 2006; 114: 4: 318-327.
  35. Marchand M., Aupart M., Norton R. et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg 2001; 71: 90050: S236-239.
  36. Myken P.S., Bech-Hansen O. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg 2009; 137: 1: 76-81.
  37. Nair V., Law K., Li A. et al. Characterizing the inflammatory reaction in explanted Medtronic Freestyle stentless porcine aortic bioprosthesis over a 6-year period. Cardiovasc Pathol 2012; 21: 3: 158-168.
  38. Newton S., Hunter S. What type of valve replacement should be used in patients with endocarditis? Int Cardiovasc Thorac Surg 2010; 11: 6: 784-788.
  39. Oakley C. Anticoagulants in pregnancy. Br Heart J 1995; 74: 2: 107-111.
  40. Oakley C. Clinical and pregnancy perspectives: anticoagulation. Eur Heart J 1995; 6: 1317-1319.
  41. Oakley R., Kleine P., Bach D.S. Choice of Prosthetic Heart Valve in Today's Practice. Circulation 2008; 117: 2: 253-256.
  42. Pibarot P., Dumesnil J. Prosthetic Heart Valves: Selection of the Optimal Prosthesis and Long-Term Management. Circulation 2009; 119: 7: 1034-1048.
  43. Pieper P., Balci A., Van Dijk A. Pregnancy in women with prosthetic heart valves. Neth Heart J 2008; 16: 12: 406-411.
  44. Rahimtoola S. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 2003; 41: 6: 893-904.
  45. Rahimtoola S. Choice of Prosthetic Heart Valve in AdultsAn Update. J Am Coll Cardiol 2010; 55: 22: 2413-2426.
  46. Rajamannan N.M., Subramaniam M., Rickard D. et al. Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype. Circulation 2003; 107: 17: 2181-2184.
  47. Renzulli A., Carozza A., Romano G. et al. Recurrent infective endocarditis: multivariate analysis of 21 years experience. Ann Thorac Surg 2001; 72: 39-43.
  48. Riess F., Cramer E., Hansen L. et al. Clinical results of the Medtronic Mosaic porcine bioprosthesis up to 13 years. Eur J Cardiothorac Surg 2010; 37: 1: 145-153.
  49. Rizzoli G., Guglielmi C., Toscano G. et al. Reoperations for acute prosthetic thrombosis and pannus: an assessment of rates, relationship and risk. Eur J Cardiothorac Surg 1999; 16: 74-80.
  50. Rizzoli G., Mirone S., Ius P. et al. Fifteen-year results with the Hancock II valve: A multicenter experience. J Thorac Cardiovasc Surg 2006; 132: 3: 602-609.
  51. Ruel M., Chan V., Bedard P. et al. Very Long-Term Survival Implications of Heart Valve Replacement With Tissue Versus Mechanical Prostheses in Adults <60 Years of Age. Circulation 2007; 116: 11: Suppl: 294-300.
  52. Shetty R., Pepin A., Charest A. et al. Expression of bone-regulatory proteins in human valve allografts. Heart 2006; 92: 9: 1303-1308.
  53. Shetty R., Pibarot P., Audet A. et al. Lipid-mediated inflammation and degeneration of bioprosthetic heart valves. Eur J Clin Invest 2009; 39: 6: 471-480.
  54. Skowasch D., Steinmetz M., Nickenig G., Bauriedel G. Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology. Expert Rev Med Devices 2006; 3: 4: 453-462.
  55. Sweeney M., Reul G., Cooley D. et al. Comparsion of bioprosthetic and mechanical valve replacement for active endocarditis. J Thorac Cardiovasc Surg 1985; 90: 676-680.
  56. The ISTHMUS Investigators. The Italian study on the Mitroflow postoperative results (ISTHMUS): a 20-year, multicentre evaluation of Mitroflow pericardial bioprosthesis. Eur J Cardiothorac Surg 2011; 39: 1: 18-26.
  57. Thiene G., Valente M. Anticalcification strategies to increase bioprosthetic valve durability. J Heart Valve Dis 2011; 20: 1: 37-44.
  58. Tillquist M., Maddox T. Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement. Patient Prefer Adherence 2011; 5: 91-99.
  59. Vahanian A., Baumgartner H., Bax J. et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 2: 230-268.
  60. Van Geldorp M., Eric Jamieson W., Kappetein A. et al. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg 2009; 137: 4: 881-886, 886e1-5.
  61. Vogt P., Brunner-LaRocca H., Sidler P. et al. Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality. Eur J Cardiothorac Surg 2000; 17: 2: 134-139.
  62. Wilhelmi M., Mertsching H., Wilhelmi M. et al. Role of inflammation in allogeneic and xenogeneic heart valve degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation. J Heart Valve Dis 2003; 12: 4: 520-526.
  63. Yu H.-Y., Ho Y.-L., Chu S.-H. et al. Long-term evaluation of Carpentier-Edwards porcine bioprosthesis for rheumatic heart disease. J Thorac Cardiovasc Surg 2003; 126: 1: 80-89.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.